US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Adynxx, Inc.

0.0000

0.0000

Volume:- -

Turnover:- -

Market Cap:5.81

PE:NAN

High:0.0000

Open:0.0000

Low:0.0000

Close:0.0000

52wk High:0.0002

52wk Low:0.0000

Shares:5.81M

Float Shares:1.00M

Volume Ratio:0.52

T/O Rate:- -

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.8194

EPS(LYR):-0.3062

ROE:120.88%

ROA:-192.35%

PB:-0.00

PE(LYR):0.00

Loading ...

Overview Company News Filings

Company Profile

Company Name:

Adynxx, Inc.

Exchange:

EXPERT

Establishment Date:

2007

Employees:

6

Office Location:

100 Pine Street,Suite 500,San Francisco,California,United States

Website:

http://www.adynxx.com

Zip Code:

94111

Phone:

Fax:

- -

Introduction:

Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ADYX/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"ADYX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADYX\",,,,,undefined,":{"symbol":"ADYX","market":"US","secType":"STK","nameCN":"Adynxx, Inc.","latestPrice":0.000001,"timestamp":1771621200000,"preClose":0.000001,"halted":0,"volume":0,"delay":15,"changeRate":0,"floatShares":1001085,"shares":5807900,"eps":-1.819425,"marketStatus":"Market Closed","change":0,"latestTime":"02-20 16:00:00 EST Delay","open":0.000001,"high":0.000001,"low":0.000001,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-1.819425,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1771837200000},"marketStatusCode":7,"adr":0,"exchange":"EXPERT","adjPreClose":0.000001,"volumeRatio":0.5188676797793964},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADYX\",,,,,undefined,":{"symbol":"ADYX","floatShares":1001085,"roa":"-192.35%","roe":"120.88%","lyrEps":-0.306154,"volumeRatio":0.5188676797793964,"shares":5807900,"dividePrice":0,"high":0.000001,"amplitude":0,"preClose":0.000001,"low":0.000001,"week52Low":0.000001,"pbRate":"-0.00","week52High":0.0002,"institutionHeld":0,"latestPrice":0.000001,"eps":-1.819425,"divideRate":0,"volume":0,"delay":15,"ttmEps":-1.819425,"open":0.000001,"prevYearClose":0.0001,"prevWeekClose":0,"prevMonthClose":0,"prevQuarterClose":0.0001,"fiveDayClose":0,"twentyDayClose":0,"sixtyDayClose":0.0001},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADYX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2019-11-14","symbol":"ADYX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1573707600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2019-08-15","symbol":"ADYX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1565841600000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2019-04-23","symbol":"ADYX","fiscalQuarterEnding":"2019/03","expectedEps":null,"name":null,"time":"","type":"earning","dateTimestamp":1555992000000,"reportTimeType":"","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADYX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADYX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":111261311,"yearFounded":2007,"employeeNum":6,"address":"100 Pine Street,Suite 500,San Francisco,California,United States","zipCode":"94111","officePhone":"415-512-7740"},"stockCompanyDetail":{"websiteUrl":"http://www.adynxx.com","stockEarnings":[{"period":"1week","weight":-0.2857},{"period":"1month","weight":-0.2},{"period":"3month","weight":-0.723},{"period":"6month","weight":-0.9435},{"period":"1year","weight":-0.9195},{"period":"ytd","weight":-0.9109}],"description":"Adynxx, Inc., a clinical stage biopharmaceutical company, focuses on the development and marketing of transcription factor decoy technologies for the treatment of pain and inflammatory diseases. It is involved in the development of AYX platform of transcription factor decoys, including brivoligide, which is in Phase II clinical development for the reduction of postoperative pain; and AYX2, a pre-clinical candidate intended for the treatment of focal chronic pain. The company was founded in 2007 and is headquartered in San Francisco, California.","exchange":"EXPERT","name":"Adynxx, Inc.","nameEN":"Adynxx, Inc."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ADYX\",market:\"US\",,,undefined,":null}}